Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

NCT07231081 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

BIOLOGICAL: Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell) Injection/TX103

Sponsor

Tcelltech Inc.